# Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-her2-immunoliposomes-enhanced-efficacy-attributable-to-targeted-delivery/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John W. Park,Keelung Hong,Dmitri B. Kirpotin,Gail Colbern,Refaat Shalaby,José Baselga,Yvonne Shao,Ulrik B. Nielsen,James D. Marks,Dan H. Moore,Demetrios Papahadjopoulos,Christopher C. Benz |
| Citations | 648 |
| Fields | Materials Science,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://escholarship.org/uc/item/5m33w7hb |
| OpenAlex ID | https://openalex.org/W2143978130 |
| PMID | 11948130 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Dan H. Moore](https://scholariq.org/researchers/dan-h-moore/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)

## Paper topics

- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.